SpartanNash Addresses Director Nominations
Macellum originally nominated a control slate while owning just 1,000 shares in December and prior…
Month: March 2022
Why Ransomware Attacks Steer Clear of the Cloud
Snyk Chief Architect Josh Stella Explains Why Attackers Aren’t Targeting Cloud Environments With Ransomware and…
All of Us Research Program Releases Genomic Data to Researchers, Combined with Participant-Generated Data Collected on Vibrent Health’s Digital Health Research Platform
Precision medicine initiative leverages innovative technologies and unprecedented 80% diverse participant base to drive new…
Nymox Announces $5 Million Registered Direct Offering
IRVINE, Calif., March 18, 2022 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced…
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Final Results for SP-102 (SEMDEXAâ„¢) Efficacy and Safety from its Pivotal Phase 3 Clinical Trial Program for Sciatica Pain Management Supporting the Potential for First to Market Opportunity
SP-102 (SEMDEXA™), with 401 patients enrolled in the C.L.E.A.R. trial (Corticosteroid Lumbosacral Epidural Analgesia in…
Reviva Pharmaceuticals Holdings, Inc. to Present at Upcoming Virtual Investor Conferences
– 5th Annual Neuroscience Innovation Forum – – BIO-Europe Spring® 2022 – CUPERTINO, Calif., March…
Palisade Bio (Nasdaq: PALI) Reports Year End 2021 Financial Results and Corporate Update
CARLSBAD, Calif., March 18, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the…
Immutep To Present Biomarker And Multivariate Analysis From Phase IIb AIPAC Study In Metastatic Breast Cancer At ESMO’s Breast Cancer Congress 2022
SYDNEY, AUSTRALIA, March 18, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Press Release: Sanofi moves forward with EUROAPI listing on Euronext Paris
Sanofi moves forward with EUROAPI listing on Euronext Paris Sanofi will give its shareholders…
Immutep Announces Second Japanese Patent Grant for LAG-3 Antagonist Antibody LAG525
SYDNEY, AUSTRALIA, March 18, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
WALTHAM, Mass., March 18, 2022 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company…
Krystal Biotech to Present at 2022 American Academy of Dermatology Annual Meeting
PITTSBURGH, March 18, 2022 (GLOBE NEWSWIRE) — Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
Decibel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
– Key anticipated catalysts in 2022 include submission of IND and/or CTA for DB-OTO and…
ASLAN Pharmaceuticals Announces Acceptance of Late-Breaking Abstract on Eblasakimab Proof-of-Concept Study in Atopic Dermatitis for Oral Presentation at the 2022 American Academy of Dermatology Annual Meeting
– Topline data from the eblasakimab Phase 1b multiple-ascending-dose study will be presented during the…
Notice of in-court restructuring proceedings of Orphazyme A/S
Orphazyme A/SCompany announcementNo. 11/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 18, 2022 – Orphazyme A/S…
LendingPoint Announces Record Growth for Second Half Of 2021
Company Achieves Second Straight Year of Profitable Growth ATLANTA–(BUSINESS WIRE)–LendingPoint, an AI-driven CreditTech platform, today…
Osprey Funds Makes Key Executive Hires and Promotes New CIO To Help Drive Growth
By deepening its leadership bench, crypto investment firm positions itself to expand business lines and…
Egan-Jones Sponsored the SuperReturn Private Credit Europe Conference in London
NEW YORK–(BUSINESS WIRE)–Egan-Jones Ratings Company was a proud sponsor of the SuperReturn Private Credit Europe…
Perfect Corp. Presents Pioneering NFT Solution with AR Virtual Try-on Capability at 2022 South by Southwest Conference
The trailblazing virtual try-on enabled NFT solution empowers beauty and fashion brands to create fully…
Macellum and Ancora Nominate Three Highly Qualified and Independent Candidates for Election to SpartanNash’s Board of Directors
Issue Letter to Shareholders Detailing the Urgent Case for Change and Outlining the Rationale for…